SCHEMBL31663596

SCHEMBL31663596

N#Cc1c(-c2ccncc2)ccc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 4/20 0.55
ADORA2A P29274 4/20 0.55
SQOR Q9Y6N5 1/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
NOTUM Q6P988 1/20 0.47
CDC7 O00311 1/20 0.45
DBF4 Q9UBU7 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MAPT P10636 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
GRM5 P41594 1/20 0.44
CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12679765 1.00 ADORA1 (0.55) ADORA1ADORA2ASQORMEN1KMT2A
SCHEMBL31663594 1.00 ADORA1 (0.55) ADORA1ADORA2ASQORMEN1KMT2A
SCHEMBL31663541 0.85 KDM4E (0.58) ADORA1ADORA2AKMT2AALDH1A1CYP19A1
SCHEMBL31663604 0.84 ADORA1 (0.56) ADORA1ADORA2ASQORMEN1KMT2A
SCHEMBL12679796 0.82 ADORA1 (0.57) ADORA1ADORA2ASQORMEN1KMT2A
SCHEMBL31663575 0.81 ADORA1 (0.46) ADORA1ADORA2ASQORMEN1KMT2A
SCHEMBL31663612 0.81 ADORA1 (0.46) ADORA1ADORA2ASQORMEN1KMT2A
SCHEMBL12679770 0.81 SQOR (0.46) ADORA1ADORA2ASQORMEN1KMT2A
SCHEMBL31663624 0.79 ADORA2A (0.45) ADORA1ADORA2ASQORMEN1KMT2A
SCHEMBL9069187 0.79 ADORA2A (0.45) ADORA1ADORA2ASQORALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 ADORA1 3690/4885ADORA2A 1368/4885SQOR 399/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 ADORA1 3690/4885ADORA2A 1368/4885SQOR 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.